Hauwanga Wilhelmina N, Alphonse Berley, Akram Ifrah, Djeagou Albine, Lima Pessôa Bruno, McBenedict Billy
Family Medicine, Federal University of the State of Rio de Janeiro, Rio de Janeiro, BRA.
Neurosurgery, Fluminense Federal University, Niterói, BRA.
Cureus. 2024 Jun 4;16(6):e61657. doi: 10.7759/cureus.61657. eCollection 2024 Jun.
Introduction Renal failure, comprising acute kidney injury (AKI) and chronic kidney disease (CKD), involves a decline or loss of kidney function. AKI is sudden and reversible, with a rapid decline in function over hours to days, while CKD involves persistent abnormalities lasting at least three months. Developing countries are seeing a rise in AKI cases, especially in critically ill patients. Globally, there's a growing occurrence and mortality rate linked to CKD. Methods The study used a retrospective cross-sectional design to analyze AKI and CKD mortality rates in Brazil from 2019 to 2022. Data on population and demographics, including sex and age, were obtained from the Brazilian Institute of Geography and Statistics. Mortality data for kidney diseases were sourced from the Brazilian Hospital Information System. The analysis utilized the Joinpoint Regression Program to calculate average annual percentage changes (AAPCs) and their respective 95% confidence intervals. Weighted Bayesian information criterion was used to determine the significance levels and identify the best-fitting combination of line segments and joinpoints. Results The study findings revealed a significant rise in AKI mortality rates for both males and females, from 2008 to 2021 (APC = 3.16; CI: 2.29 to 5.93), with higher mortality rates recorded among males compared to women over the entire study period. Analyses according to age groups showed that males between the ages 40 to 49 experienced the most rapid increase in mortality during the 2019 - 2021 period (APC = 35.41; CI: 16.72 to 46.57); meanwhile, the most rapid increase in mortality for females was observed from 2019 to 2021, and this was among those aged 30 to 39 (APC = 40.33; CI = 6.48 to 59.78). Furthermore, there was an observable upward trend in mortality related to CKD (APC = 0.70; CI: 0.41 to 1.01), with males consistently having higher mortality rates throughout the entire study period. The elderly population, both males and females, experienced the most rapid increase in CKD-related mortality, with AAPC values of 2.32 (CI: 1.82 to 2.89) for males and 1.62 (CI: 1.08 to 2.10) for females. Conclusion We observed a consistent increase in mortality rates from acute kidney diseases for both males and females since 2008, with males experiencing higher mortality rates overall. The study highlighted the need for further research to understand the underlying factors contributing to these trends. Additionally, interventions targeting modifiable risk factors and improving access to healthcare could help reduce mortality related to renal failure.
引言
肾衰竭包括急性肾损伤(AKI)和慢性肾病(CKD),涉及肾功能的下降或丧失。急性肾损伤是突然发生且可逆的,其功能在数小时至数天内迅速下降,而慢性肾病则涉及持续至少三个月的异常情况。发展中国家急性肾损伤病例呈上升趋势,尤其是在危重症患者中。在全球范围内,与慢性肾病相关的发病率和死亡率都在上升。
方法
本研究采用回顾性横断面设计,分析2019年至2022年巴西急性肾损伤和慢性肾病的死亡率。关于人口和人口统计学的数据,包括性别和年龄,来自巴西地理与统计研究所。肾脏疾病的死亡率数据来自巴西医院信息系统。分析利用Joinpoint回归程序计算平均年度百分比变化(AAPC)及其各自的95%置信区间。加权贝叶斯信息准则用于确定显著性水平,并确定线段和连接点的最佳拟合组合。
结果
研究结果显示,2008年至2021年期间,男性和女性的急性肾损伤死亡率均显著上升(APC = 3.16;CI:2.29至5.93),在整个研究期间,男性的死亡率高于女性。按年龄组分析表明,40至49岁的男性在2019 - 2021年期间死亡率上升最快(APC = 35.41;CI:16.72至46.57);与此同时,女性死亡率上升最快的是2019年至2021年期间,且是在30至39岁的女性中(APC = 40.33;CI = 6.48至59.78)。此外,与慢性肾病相关的死亡率呈明显上升趋势(APC = 0.70;CI:0.41至1.01),在整个研究期间男性死亡率一直较高。老年人群,包括男性和女性,慢性肾病相关死亡率上升最快,男性的AAPC值为2.32(CI:1.82至2.89),女性为1.62(CI:1.08至2.10)。
结论
我们观察到自2008年以来,男性和女性急性肾病的死亡率持续上升,总体上男性死亡率更高。该研究强调需要进一步研究以了解导致这些趋势的潜在因素。此外,针对可改变的风险因素并改善医疗保健可及性的干预措施有助于降低与肾衰竭相关的死亡率。